Sign In
Buy ALPN
$64.97
+0 (+0%)
At Close: Aug 19, 2024
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q4 2020 Results - Earnings Call Transcript
10:32pm, Thursday, 18'th Mar 2021
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q4 2020 Results - Earnings Call Transcript
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue Estimates
06:33pm, Thursday, 18'th Mar 2021
Alpine Immune Sciences, Inc. (ALPN) delivered earnings and revenue surprises of 0.00% and 101.39%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for t
Alpine Immune Sciences Announces Poster Presentations at AACR Virtual Annual Meeting I
04:30pm, Wednesday, 10'th Mar 2021
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences Announces Poster Presentations at AACR Virtual Annual Meeting I
7 Micro-Cap Stocks That Are Worth the Risk
09:05am, Thursday, 07'th Jan 2021
Although micro-cap stocks don't perform well during an economic downturn, they outperform the market during periods of recovery. Here are 7 stocks to invest in as we head toward a new normal.
Alpine: Is This A Young Oak Tree?
01:22pm, Tuesday, 05'th Jan 2021
Alpine Immune Sciences is a stellar growth bio-stock that is reaching a point of growth inflection. Back in June last year, Alpine secured a highly favorable partnership with AbbVie.
These 4 Micro-Cap Healthcare Stocks Gained the Most in 2020
07:04am, Friday, 01'st Jan 2021
Innovation paid off big for investors.
Alpine Immune Sciences Appoints Natasha Hernday to Board of Directors
08:00am, Friday, 11'th Dec 2020
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences Appoints Natasha Hernday to Board of Directors
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call Transcript
07:24pm, Thursday, 12'th Nov 2020
Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2020 Results - Earnings Call Transcript
The Peck Company Holdings Expands into Rhode Island with $7.256 Million EPC Contract for a 5.3MW Solar Project
12:00am, Wednesday, 07'th Oct 2020
The Peck Company Holdings, Inc. (NASDAQ: PECK) (the “Company” or “Peck”), a leading commercial solar engineering, procurement and construction (EPC) c
Alpine Immune Sciences (ALPN) Investor Presentation - Slideshow
06:03pm, Thursday, 13'th Aug 2020
The following slide deck was published by Alpine Immune Sciences, Inc. in conjunction with this event..
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
08:05pm, Tuesday, 11'th Aug 2020
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
12:00am, Tuesday, 11'th Aug 2020
Alpine Immune Sciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Alpine Immune Sciences to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
08:05pm, Wednesday, 05'th Aug 2020
Alpine Immune Sciences to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate Update
08:05pm, Tuesday, 04'th Aug 2020
Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate Update
Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate Update
12:00am, Tuesday, 04'th Aug 2020
Alpine Immune Sciences to Report Second Quarter 2020 Financial Results and Provide Corporate Update
